APOPTOSIS

Scope & Guideline

Connecting Research in Biochemistry and Beyond

Introduction

Immerse yourself in the scholarly insights of APOPTOSIS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1360-8185
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1996 to 2024
AbbreviationAPOPTOSIS / Apoptosis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'APOPTOSIS' primarily focuses on the mechanisms, implications, and therapeutic potential of programmed cell death in various biological contexts, particularly in cancer and other diseases. It encompasses a wide range of research areas that explore the interplay between cell death pathways and disease processes, emphasizing innovative methodologies and translational applications.
  1. Mechanisms of Programmed Cell Death:
    Research articles frequently delve into the molecular mechanisms underlying various forms of programmed cell death, including apoptosis, pyroptosis, ferroptosis, and necroptosis. Understanding these pathways is crucial for developing targeted therapies.
  2. Therapeutic Applications:
    The journal emphasizes the application of knowledge about cell death mechanisms to develop therapeutic strategies for diseases, particularly cancer. This includes the exploration of drug candidates that induce or inhibit specific cell death pathways.
  3. Cellular Interactions and Microenvironment:
    Studies often investigate how cell death processes interact with the tumor microenvironment, immune responses, and cellular signaling networks, highlighting the complexity of these interactions in disease progression and therapy.
  4. Biomarkers and Prognostic Signatures:
    Research frequently includes the identification of biomarkers associated with cell death pathways that can serve as prognostic indicators or therapeutic targets in various cancers and diseases.
  5. Innovative Methodologies:
    The journal publishes studies utilizing advanced techniques such as single-cell transcriptomics, machine learning, and molecular imaging to investigate cell death mechanisms and their implications in health and disease.
Recent trends in 'APOPTOSIS' highlight a dynamic evolution in the field of cell death research, with several emerging themes gaining traction. These trends reflect the increasing complexity of cell death mechanisms and their implications in various therapeutic contexts.
  1. Ferroptosis and Cuproptosis:
    Research on ferroptosis and cuproptosis is rapidly increasing, reflecting a growing interest in these novel forms of regulated cell death and their potential therapeutic implications in cancer and other diseases.
  2. Integration of Machine Learning and Bioinformatics:
    The use of machine learning and bioinformatics tools to analyze cell death pathways and predict therapeutic outcomes is emerging as a significant trend, allowing for more precise and personalized approaches in cancer treatment.
  3. Interplay Between Cell Death and Immune Response:
    There is a rising focus on understanding how different forms of cell death interact with the immune system, particularly in the context of cancer immunotherapy, highlighting the importance of immune modulation.
  4. Targeting the Tumor Microenvironment:
    Research is increasingly addressing how cell death mechanisms can be influenced by the tumor microenvironment, emphasizing the need for therapies that not only target cancer cells but also modulate surrounding tissues.
  5. Novel Biomarkers for Prognosis and Therapy:
    The identification of new biomarkers related to various cell death pathways is gaining importance for predicting patient outcomes and guiding treatment decisions, particularly in oncology.

Declining or Waning

While 'APOPTOSIS' covers a broad spectrum of cell death research, certain themes have diminished in recent publications, reflecting shifts in research focus and emerging technologies. The following areas appear to be declining in prominence.
  1. Traditional Apoptosis Pathways:
    There has been a noticeable shift away from classic apoptosis studies, particularly those focusing solely on caspase-mediated pathways. Research is increasingly integrating more complex and diverse forms of regulated cell death like ferroptosis and pyroptosis.
  2. Cell Death in Non-Cancerous Diseases:
    While cell death mechanisms in cancer remain a strong focus, studies addressing apoptosis in non-cancerous diseases such as neurodegeneration or cardiovascular diseases have become less frequent, indicating a narrowing of the journal's thematic scope.
  3. In Vitro Studies:
    There is a declining trend in articles focused solely on in vitro studies of apoptosis in isolated cell lines. Research is increasingly emphasizing in vivo studies and translational approaches that consider the complexity of living organisms.
  4. General Reviews on Apoptosis Mechanisms:
    Comprehensive reviews solely summarizing apoptosis mechanisms without new insights or applications are becoming less common, as the journal favors articles that present novel findings or methodologies.

Similar Journals

BMC Molecular and Cell Biology

Bridging knowledge gaps in the biological sciences.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Cell Communication and Signaling

Illuminating the Pathways of Cellular Dialogue
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

CELL RESEARCH

Illuminating the Pathways of Life Sciences
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

JOURNAL OF CELLULAR BIOCHEMISTRY

Fostering Excellence in Cellular Biochemistry Research
Publisher: WILEYISSN: 0730-2312Frequency: 12 issues/year

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

CELL PROLIFERATION

Empowering Global Collaboration in Cell Biology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

CELLULAR AND MOLECULAR BIOLOGY

Pioneering Discoveries in Cell Biology
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

Anti-Cancer Agents in Medicinal Chemistry

Empowering researchers with cutting-edge insights in oncology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1871-5206Frequency: 10 issues/year

Anti-Cancer Agents in Medicinal Chemistry is a pivotal journal in the realm of cancer research, published by Bentham Science Publishers in the United Arab Emirates. With an ISSN of 1871-5206 and an E-ISSN of 1875-5992, this esteemed journal has been disseminating high-quality research since its inception in 2006, and is set to continue through 2024. The journal is categorized in the third quartile (Q3) across key areas including Cancer Research, Molecular Medicine, and Pharmacology, highlighting its essential role in providing valuable insights to the scientific community. Despite its open-access status being unspecified, researchers benefit from the rigorous peer-review process ensuring the publication of significant advancements. The journal ranks well within Scopus, particularly in the fields of Pharmacology and Cancer Research, which positions it as a notable resource for professionals, students, and researchers aiming to deepen their knowledge in anti-cancer strategies. Through its comprehensive scope, the journal aims to bridge the gap between medicinal chemistry and clinical applications, making it an indispensable tool for those dedicated to advancing cancer therapeutics.

NATURE REVIEWS MOLECULAR CELL BIOLOGY

Elevating research through comprehensive reviews in cell biology.
Publisher: NATURE PORTFOLIOISSN: 1471-0072Frequency: 12 issues/year

NATURE REVIEWS MOLECULAR CELL BIOLOGY, published by NATURE PORTFOLIO, stands as a seminal journal in the fields of cell and molecular biology, with a significant impact factor that underscores its influence and reputation within the scientific community. Established in 2000 and continuing its legacy into 2024, this journal delivers comprehensive reviews that synthesize current knowledge and advancements in molecular and cellular processes. Respected for its high-quality articles, it has maintained a prestigious Q1 ranking in both Cell Biology and Molecular Biology categories as of 2023. With an exceptional Scopus ranking, taking the top position in its category, it attracts a readership of prominent researchers, professionals, and students eager to stay abreast of groundbreaking discoveries and methodologies. Although it does not offer Open Access, subscribers benefit from exclusive access to vital insights that foster innovative research approaches and advancements in the life sciences. The journal’s objective is to bridge the gap between research and application, providing indispensable resources to its audience while contributing to the global conversation on molecular and cellular biology.

BIOSCIENCE REPORTS

Illuminating Breakthroughs in Biochemistry and Beyond
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

Analytical Cellular Pathology

Advancing the Frontiers of Cellular Insights
Publisher: HINDAWI LTDISSN: 2210-7177Frequency:

Analytical Cellular Pathology, published by Hindawi Ltd, is a leading journal in the disciplines of Cancer Research, Cell Biology, and Pathology, and has been dedicated to advancing the field through open access since 1997. Based in Egypt, this journal plays a crucial role in disseminating cutting-edge research and innovative findings, fostering collaboration among researchers and professionals alike. With an impressive array of metrics, including its Q2 ranking in Pathology and Forensic Medicine and notable Scopus rankings, the journal attracts a diverse readership, ensuring significant impact in its categories. Designed to cater to the needs of both emerging and established scholars, Analytical Cellular Pathology promotes accessibility and exchange of knowledge, making it an indispensable resource for those engaged in modern cellular pathology research.